The presence of endotoxins in preparations of recombinantly produced therapeutic proteins poses serious problems for patients. Endotoxins can cause fever, respiratory distress syndromes, intravascular coagulation, or endotoxic shock. A number of methods have been devised to remove endotoxins from protein preparations using separation procedures based on molecular mass or charge properties. Most of the methods are limited in their endotoxin removal capacities and lack general applicability. We are describing a biotechnological approach for endotoxin removal. This strategy exploits the observation that endotoxins form micelles that expose negative charges on their surface, leading to preferential binding of endotoxins to cationic surfaces, allowing the separation from their resident protein. Endotoxins exhibit high affinity to stretches of histidines, which are widely used tools to facilitate the purification of recombinant proteins. They bind to nickel ions and are the basis for protein purification from cellular extracts by immobilized metal affinity chromatography. We show that the thrombin-mediated cleavage of two histidine tags from the purified recombinant protein and the adsorption of these histidine tags and their associated endotoxins to a nickel affinity column result in an appreciable depletion of the endotoxins in the purified protein fraction.
Recombinant DNA technology and the development of efficient protein expression systems have led to the production and therapeutic deployment of a large number of biopharmaceuticals. More than 200 biopharmaceuticals produced in bacteria, yeast, and mammalian cell cultures have been approved by the regulatory agencies. Roughly one-third of these molecules have been derived from Escherichia coli, and most recombinant proteins are expressed in the bacterial cytoplasm [1] . They can be directed to the periplasm, deposited in the inner or outer membrane, or secreted in the growth medium. The yield of bacterially expressed proteins and their purification procedures have been optimized by biotechnologists, and efficient protocols associated with low costs have been established [1] [2] [3] .
A persistent problem associated with the production of recombinant proteins in bacteria is the presence of endotoxins in purified protein preparations. Endotoxin removal from recombinant protein preparations often involves elaborate and expensive procedures. In addition, such procedures lack general applicability and can be limited in their endotoxin removal capacity. We wanted to overcome these limitations and devise a general approach for the endotoxin depletion of recombinantly expressed proteins. Our endotoxin removal strategy from bacterially expressed proteins is based on the preferential binding of endotoxins to a stretch of cationic histidines and the possibility to absorb this polyhistidine-endotoxin complex onto nickel affinity columns.
Endotoxins are lipopolysaccharides (LPSs) 1 and are an integral part of the outer cell membrane of gram-negative bacteria [4] . They consist of a lipid component (lipid A), a core oligosaccharide, and a long heteropolysaccharide chain, the strain-specific bacterial surface O-antigen [5] [6] [7] . Lipid A is thought to be responsible for most of the biological activities of endotoxins [1, 2] . Endotoxins are released on bacterial cell death [3] . They are rather heat stable and can form aggregates in the presence of divalent cations. The aggregates display negative charges on their surface and can be adsorbed to cationic materials through their phosphate groups [5] . Endotoxins can trigger strong biological reactions when introduced into the bloodstream [6, 8] . They can cause fever, hypotension, respiratory distress syndromes, intravascular coagulation, and endotoxic shock. Sepsis is a systemic inflammatory response to gram-negative bacteria infections and initiated by LPS. It stimulates the synthesis of the inflammatory cytokines IL-1b (interleukin 1b), IL-6, IL-10, and TNF-a [1, 4] .
The molecular mechanisms that mediate endotoxin actions have been well characterized. LPS can activate TLR4, a member of the family of toll-like receptors (TLRs) expressed by cells of the innate immune system that recognize structural motifs characteristic of pathogen-associated molecular patterns (PAMPs) [9] . LPS interaction with TLR4 is mediated by a number of additional proteins (e.g., LPS binding protein [LBP], CD14, MD-2 [10, 11] ) and eventually causes the expression of proinflammatory cytokines. LPS mediates TLR4 oligomerization and the recruitment of downstream adaptor molecules such as MyD88 (myeloid differentiation primary response gene 88), TIRAP (TIR domain-containing adaptor protein), TRIF (TIR domain-containing adaptor-inducing IFN-b), TRAM (TRIF-related adaptor molecule), and SARM (sterile alpha and HEAT/Armadillo motif-containing protein) [12] .
LPS induction of the TLR4 receptor complex (e.g., in macrophages) activates intracellular signal transduction pathways and autocrine and paracrine signaling events. The p38 MAPK and Stat3 signal transduction pathways play central roles. They control the induction and duration of the inflammatory macrophage response [13] [14] [15] . Because LPS is a strong activator of Stat3, we used the treatment of macrophages and the phosphorylation status of Stat3 as a read-out for LPS-induced signaling and compared recombinant protein preparations before and after the depletion procedure. We expect that the depletion of LPS in the rS3-PA protein preparation causes reduced Stat3 phosphorylation.
Gram-negative bacteria release endotoxins when their cell wall is disrupted by sonication during the lysis process. The protein purification steps need to take this into account, and therapeutic proteins must be shown to be free of endotoxins before they can be used.
A number of methods have been described for the removal of endotoxins from recombinant proteins [6, 16] . Diverse separation procedures such as ultrafiltration, anion exchange chromatography, membrane-based chromatography, polymyxin B immobilized on Sepharose 4B, and the application of two-phase micellar systems have been employed [5, 6] . In addition, the use of activated charcoal, modified cellulose, and chitosan microfiltration membranes are being considered [7] . The methods used to remove endotoxins often employ detergents combined with phase separation and affinity chromatography and need to be adjusted to the biochemical properties of the protein to be purified (e.g., the amino acid composition and the charge properties) [17] . There is currently no method available that can be generally used for all bacterially expressed proteins.
Endotoxin concentrations during the protein purification process can be independently monitored by the limulus amebocyte lysate (LAL) test (e.g., from Charles River Laboratories) [18] . In the presence of endotoxins, the hemolymph of the limulus polyphemus agglutinates. There are several test kits available with different sensitivities and also chromogenic assays in which the concentration of LPS can be determined.
We established a strategy for endotoxin removal from bacterial lysates with a model protein. This protein is a peptide aptamer construct, rS3-PA. It incorporates a short peptide sequence that specifically recognizes and inhibits the function of the transcription factor Stat3 [19] [20] [21] [22] . The construct encoding rS3-PA is shown in Fig. 1 . The Stat3 recognizing peptide sequence is embedded in the human thioredoxin, which serves as a scaffold protein. It also contains histidine tags, 10 consecutive histidine residues, at its amino and carboxyl termini. We hypothesized that the contaminating endotoxins are mainly associated with the histidine tags [7, 23] used in our strategy for the endotoxin depletion of proteins produced in E. coli and purified from the bacterial lysates. We introduced two thrombin cleavage sites next to the histidine tags. We compared the endotoxin activity in the rS3-PA preparations before and after the cleavage and a second step of nickel affinity chromatography. We observed a drastic LPS depletion in the recombinant protein fraction devoid of the histidine tags. The depleted protein contains highly reduced LPS content and is not able to induce Stat3 activation in macrophages.
Materials and methods

Insertion of thrombin recognition motifs into the pET 30 a+ bacterial expression vector
Thrombin is a protease with an important role in blood coagulation. It recognizes the amino acid sequence Leu-Val-Pro-Arg/GlySer and cleaves between the arginine and glycine residues. We designed oligonucleotides of the following sequences and used them to introduce thrombin cleavage sites into the bacterial expression vector:
These oligonucleotides were annealed in a buffer consisting of 100 mM NaCl and 50 mM Hepes (pH 7.4). In a first step, the reaction was denatured at 95°C for 10 min, and thereafter the temperature was decreased every 2 min by 5°C until the temperature reached 4°C. These oligonucleotides were then restricted with EcoRI (New England Biolabs, Ipswich, MA, USA) and XhoI (New England Biolabs), run on a 2% agarose gel, isolated, and purified. These restricted oligonucleotides were then inserted into the pET 30 a+ vector and digested with EcoRI and XhoI. Ligation with T4 ligase (New England Biolabs) at 16°C overnight led to an insertion of the thrombin recognition motif between the C terminus of the protein and the histidine tag ( Fig. 1 ).
Transformation in BL21-CodonPlus (DE) bacteria
The rS3-PA gene was cloned into bacterial expression vectors, pET 30 a+ for thrombin cleavage and pFlag as a control vector with only one histidine tag at the carboxyl terminus. The plasmids were transformed into BL21-CodonPlus bacteria (Stratagene, Agilent Technologies, Santa Clara, CA, USA). These bacteria are specifically suited for high-yield protein expression based on the strength of the T7 promoter. For the transformation process, 100 ll of Top10 F 0 bacteria was thawed on ice for 15 min. Then 5 ll of H 2 O and 5 ll of the ligation reaction were transferred into a 1.5-ml tube on ice. Next 100 ll of the bacteria was added and carefully mixed without vortexing. The mixture was kept on ice for approximately 30 min. Thereafter, the mixture was heat shocked at 42°C for 1 min and subsequently incubated on ice for 2 min. Then 1 ml of LB (Luria-Bertani broth) medium at room temperature was added. This solution was incubated at 37°C for 1 h and shaking at 350 rpm. The mixture was centrifuged for 1 min at 12,000 rpm, and the supernatant was removed except for 50 ll. This 50 ll was used to resuspend the bacterial pellet, and the bacteria were plated on agar dishes containing 50 lg/ml kanamycin (AppliChem, Darmstadt, Germany). The plates were left to dry and finally incubated at 37°C overnight.
Culturing BL21-CodonPlus (DE3) clones
A 20-ml LB medium preculture containing 50 lg/ml kanamycin was inoculated with one bacterial clone. After 5 to 8 h at 37°C with 200 rpm, this preculture was transferred into 1 to 2 L of TB (Terrific Broth) medium. Chloramphenicol (Sigma-Aldrich, 50 lg/ml) was also added to ensure that the pACYC plasmid stays within the strain. This plasmid is essential for the survival of the BL21-CodonPlus bacteria. The bacterial culture was than incubated overnight at 200 rpm and 37°C until the optical density at 600 nm reached a value between 4 and 5. Then the bacteria were collected by centrifugation at 4000 rpm for 20 min.
Protein purification
The pelleted bacteria were resuspended in 30 ml of buffer A (8 M urea [AppliChem], 500 mM NaCl [AppliChem], and 1Â phosphate-buffered saline [PBS, Life Technologies, Darmstadt, Germany], pH 7.5) per 500 ml of TB culture medium on ice. The lysate was sonicated three times on ice for 1 min with an output control of 3 W and at a duty cycle of 70% with a homogenizer (Ultra Turray T 25, IKA Werke, Staufen, Germany) to disrupt the cells. The sonicated lysate was centrifuged at 9500 rpm for 30 min at 4°C. The supernatant was filtered with paper and transferred to the superloop of the Äkta FPLC (fast protein liquid chromatography) device (GE Healthcare, Freiburg, Germany). The purification process is based on nickel affinity chromatography. For this purpose, a HiTrap 1-ml chelating column from GE Healthcare was first washed with 5 ml of buffer A for equilibration and then loaded with 1 ml of 0.1 M NiSO 4 solution. The analysis program used on the Äkta FPLC device was Unicorn 4.11.
After loading the protein solution to the superloop, the protein was channeled through the nickel-loaded column at a speed of 1 ml/min to ensure efficient binding. Unbound protein was washed out by additional buffer A running over the HiTrap column and collected. In the next step, nonspecifically bound proteins were washed from the column by increasing the concentration of imidazole (AppliChem) in buffer B (8 M urea, 500 mM NaCl, 1Â PBS, and 1 M imidazole, pH 7.5), which was used to wash the HiTrap column. This was done in two gradient shifts. The first one increased the imidazole concentration from 0 to 40 mM, and the second one shifted it from 40 to 80 mM. To elute the bound histidine-tagged proteins from the column, the concentration of imidazole was increased to 300 mM. Increasing imidazole concentrations result in higher stringency of binding of histidine-tagged proteins to NiSO 4 . The eluted proteins were collected in 1-ml fractions and stored on ice.
Dialysis
The protein concentrations in the eluted fractions were determined by Bradford assays, and the ones that exceeded 2 lg/ll were pooled. They were transferred into a dialysis bag (Snake Skin, Thermo Fisher Scientific, Dreieich, Germany) that left the protein enough space to float. The dialysis was performed with 400 mM arginine, 250 mM NaCl, and 10% glycerol (AppliChem) at pH 7.5 in PBS for 20 h at 4°C. During this process, the dialysis was slowly rotating. The concentration of the proteins in the dialysis bags was at least 2 lg/ll during the process.
The dialyzed protein was then dialyzed a second time in a solution containing 50 mM Tris and 300 mM NaCl at pH 7.5 (cleavage buffer) in preparation for the thrombin cleavage [8] . The dialysis was performed at 4°C with slow rotation overnight. The next morning, 25% of the dialysis buffer was replaced every 2 h with 10% glycerol and PBS. This led to a gradual reduction in the concentration of salts and arginine in the final protein preparation, a requirement for the refolding process. After four exchanges of dialysis buffer against glycerol and PBS, the whole dialysis bath had been exchanged and the dialysis process was finished. The protein was centrifuged at 4°C and 9500 rpm for 30 min to remove precipitated material. The protein was then split into 500-ll aliquots and frozen at À20°C.
Thrombin cleavage
The protocol for thrombin cleavage followed the description by Hefti and coworkers [24] . Thrombin (Sigma-Aldrich) was dissolved in 50 mM Tris, 300 mM NaCl, and 2.5 mM CaCl 2 (AppliChem) at pH Fig.1 . Experimental strategy described in this article to obtain recombinant protein preparation largely free of contamination endotoxins. The procedure is based on the introduction of thrombin cleavage sites between amino terminal and carboxy terminal histidine tags and a recombinant protein of interest. The pET 30 a+ bacterial expression vector is equipped with an endogenous N-terminal thrombin recognition site. A second site was introduced at the C terminus by oligonucleotide insertion, represented by the thrombin cleavage motif (LVPRGS). Removal of the histidine tags on thrombin cleavage and nickel chromatography leads to reduced endotoxin levels in the purified recombinant protein preparation.
7.5 to a concentration of 100 NIH units (where 1 NIH unit = 0.324 ± 0.073 lg) (Sigma-Aldrich). The rS3-PA peptide aptamer was incubated with thrombin in a molar ratio of 1:500 for different lengths of time at 37°C in a heating block. At indicated time points (3, 24, 48, 72 , and 96 h), 100-ll aliquots were taken for analysis. The uncleaved rS3-PA and the samples taken at the different time points were loaded onto a 15% SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) gel, and Western blotting was performed. The protein was detected with an anti-human thioredoxin antibody (Cell Signaling, Danvers, MA, USA) in Western blot analysis, which still contained both rS3-PA versions (Figs. 1 and 2A) .
Removal of cleaved histidine tags
The proteins cleaved by thrombin were subjected to a second round of nickel affinity chromatography. This allowed the separation of rS3-PA from the histidine tags. The removal of the histidine tags was confirmed by Western blotting analyses with anti-human thioredoxin and anti-histidine tag antibodies.
Cell culture
The murine macrophage cell line RAW 264.7 responds to the exposure to endotoxin with the activation of the transcription factor Stat3. This can be visualized by a specific antibody that recognized tyrosine phosphorylated Stat3. These cells were used to show the removal of endotoxin from the purified rS3-PA preparations. The cells were seeded in 6-well plates and cultivated to attach overnight. The next day, they were used for Stat3 induction experiments. Cells were treated with LPS (Sigma-Aldrich, 500 g/ ml), rS3-PA (uncleaved pET), rS3-PA (uncleaved pFLAG), rS3-PA (cleaved 1:50), or rS3-PA (cleaved 1:500) or were not treated at all for 6 h. Afterward, whole cell lysates were prepared and a Western blot was performed with 35 lg of protein.
Antibodies
Specific antibodies were incubated with the nitrocellulose Western blot membrane with 5% bovine serum albumin (BSA) in 0.1% TBS-T (Tris-buffered saline with 0.01% Tween 20) (1:1000) at 4°C overnight to allow binding. We used P-Stat3 (XP, Cell Signaling), Stat3 (Santa Cruz Biotechnology, Heidelberg, Germany), hTrx (XP), HIS (HIS tag antibody which recognizes tags comprised of six histidine residues; Sigma-Aldrich), actin (Sigma-Aldrich), and tubulin (Sigma-Aldrich). The secondary antibody directed against rabbit antibodies was obtained from Cell Signaling, and anti-mouse antibodies were obtained from Sigma-Aldrich.
Determination of endotoxins
In this work, the endotoxin content was verified with the ToxinSensor Chromogenic LAL Endotoxin Assay Kit (Genscript, Piscataway, NJ, USA). This test was performed and the concentrations of endotoxin were calculated according to the manufacturer's guidelines (Fig. 3) with the formula 0.2618 * x À 0.0012 (where x is the adsorbance at 545 nm of each sample).
Results and discussion
Introduction of thrombin cleavage sites into expression vector of recombinant Stat3 peptide aptamer (rS3-PA)
The gene encoding the recombinant protein, rS3-PA, was inserted into a pET30 a+ bacterial expression vector and histidine tags, 10 consecutive histidine residues, were added to the amino and carboxyl termini. In addition, thrombin cleavage sites were inserted (LVPR/GS) between the histidine tags and the termini of the rS3-PA protein (Fig. 1) . The resulting protein was expressed at high levels in E. coli and purified by nickel affinity chromatography as described in detail in earlier publications [19] [20] [21] . These protein fractions still contained appreciable levels of endotoxins. We hypothesized that the contaminating endotoxins were primarily associated, and thus copurified, with the histidine tags [7, 23] . For this reason, we devised a strategy in which we separated the purified protein from the histidine tags and the contaminating endotoxins.
The procedure entails a two-step protocol. In a first step, the rS3-PA sequence is cleaved from the histidine tags through the enzymatic action of thrombin. In a second step, the liberated histidine stretches and their associated endotoxins were separated from the recombinant protein by affinity chromatography to immobilized nickel ions. The thrombin cleavage reaction was monitored after increasing times of digestion, and protein samples were analyzed by Western blot analysis and quantified by ImageJ ( Fig. 2A and B) [9] . The antibody specific for the human thioredoxin scaffold, into which the peptide aptamer had been inserted, recognized both the original rS3-PA protein and the cleaved version. The thrombin cleavage seems to be complete after 24 h of incubation ( Fig. 2A) . The histidine tag-specific antibody recognizes the original rS3-PA but not the thrombin-cleaved product, which is devoid of histidine tags after the thrombin cleavage (Fig. 2C) . The peptide aptamer rS3-PA and the rS3-PA devoid of histidine tags differ in size by approximately 2 kDa. The Coomassie staining pattern of the gel shown in Fig. 2D confirms the predicted size differences between the rS3-PA versions before and after the thrombin cleavage. These results demonstrate that the histidine tags can be efficiently cleaved from the recombinant protein.
We subjected the thrombin-cleaved rS3-PA to a second round of nickel affinity chromatography. Because the affinity for the nickel column is dependent on the histidine tags, the thrombin-cleaved rS3-PA is not expected to be retained and should elute with the flow-through. The histidine tags themselves, however, should be retained and, thus, should be separated from the rS3-PA moiety. Endotoxins have a strong affinity to the histidine residues, and it can be expected that they are preferentially retained on the nickel column during the second chromatography step [10] . Thrombin cleavage and a second round of nickel affinity chromatography separate rS3-PA from the histidine tags and should cause a strong endotoxin depletion.
We tested whether the cleavage process and the second nickel column resulted in a reduction of endotoxins in the rS3-PA fraction devoid of the histidine tags. For this purpose, we used the LAL assay. This assay is widely used to detect and quantitate endotoxins originating from gram-negative bacteria. In our experiments, a chromogenic LAL test (Toxic Sensor Chromogenic LAL Endotoxin Assay Kit, Genscript) was used to determine the amount of endotoxins (Fig. 3) . This test demonstrated that the preparation of the thrombin-cleaved version of rS3-PA, obtained in the flow-through of the second nickel column, contains approximately 10-fold less endotoxins than the rS3-PA preparation retained on the column after the first chromatography step. It also indicates that the endotoxins are primarily associated with the histidine tags.
Thrombin-cleaved rS3-PA is devoid of Stat3 phosphorylating activity
Because we observed variable extents of Stat3 inhibition by rS3-PA in earlier experiments, depending on particular protein preparations [22] , we suspected that the residual endotoxins present in these preparations might be the cause. The endotoxins can counteract the inhibitory rS3-PA function and induce the activation of the target molecule Stat3 through the TLR pathway and by the induction of autocrine IL-6 stimulation. Therefore, we measured Stat3 activation in macrophages exposed to rS3-PA with or devoid of the histidine stretches and their associated LPS. For this purpose, we treated RAW 264.7 cells with uncleaved or thrombin-cleaved rS3-PA preparations. Stat3 can be activated in this murine macrophage cell line on exposure to LPS. The cells were cultivated and incubated with medium, LPS (500 ng/ml), uncleaved rS3-PA (pET, 2 lM), uncleaved rS3-PA (pFlag, 2 lM), cleaved rS3-PA (2 lM, 1:500 ratio), and cleaved rS3-PA (2 lM, 1:50 ratio) for 6 h. Afterward, the cells were harvested, protein extracts were prepared, and Stat3 activation was analyzed by Western blotting with a phospho-Stat3-specific antibody.
We observed that Stat3 activation could be achieved by treating the cells with LPS (500 ng/ml). A similar extent of Stat3 activation was found when the cells were exposed to uncleaved rS3-PA (Fig. 4, lanes 3 and 4) . However, no activation of Stat3 was detected in cells treated with rS3-PA cleaved with thrombin and subjected to a second round of affinity chromatography (Fig. 4, lanes 5 and Fig.4 . rS3-PA devoid of its histidine tags shows significantly reduced endotoxin contamination as visualized by the capacity to activate Stat3 in murine macrophages. RAW 264.7 cells either were left untreated or were treated with LPS (500 ng/ml), rS3-PA (uncleaved, pFLAG, 2 lM), rS3-PA (uncleaved, pET, 2 lM), rS3-PA (cleaved with thrombin in a molar ratio of 1:500, 2 lM), or rS3-PA (cleaved with thrombin in a molar ratio of 1:50, 2 lM). The LPS stimulation (lane 2) led to induction of phosphorylation of Stat3 to a similar extent as the uncleaved proteins (lanes 3 and 4) . Both cleaved versions of rS3-PA resulted in a much lower level of PStat3 (lanes 4 and 5) . Ab, antibody. 6 ). This confirms the LAL-based endotoxin assays and indicates that the two-step purification procedure allows a drastic depletion of contaminating LPS.
Concluding remarks
This study demonstrates a new approach to reduce the amount of endotoxins in bacterially expressed proteins in a relatively cheap and time-saving fashion. It is based on the introduction of thrombin cleavage sites between the protein of interest and the histidine tags used for the purification of the recombinant protein by nickel affinity chromatography. On a first step of nickel affinity chromatography, in which the recombinant protein is retained on the column, thrombin treatment is used to cleave off the histidine tags. The cleaved protein is subjected to a second round of nickel affinity chromatography in which the histidine tags and associated endotoxins, but not the recombinant protein of interest, are retained. The protein, depleted from endotoxins, can be recovered in the flow-through. This approach will be applicable for many different proteins independent of their amino acid composition or electrostatic properties. We demonstrated that this strategy can be successfully employed for a membrane-permeating Stat3 inhibitor.
